Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study

Prone Positioning in Severe Acute Respiratory Distress Syndrome

(2013) Claude Guérin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome

(2011) Tsukasa Nakamura et al.   CLINICAL BIOCHEMISTRY

Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients*

(2011) Matthieu Jabaudon et al.   CRITICAL CARE MEDICINE

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial

(2011) H. M. Colhoun et al.   DIABETES

Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome

(2010) Laurent Papazian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications

(2009) Francesca Santilli et al.   CURRENT MEDICINAL CHEMISTRY

Human S100A12: a novel key player in inflammation?

(2008) Jens Pietzsch et al.   AMINO ACIDS

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

(2008) C S Calfee et al.   THORAX